Trevi Therapeutics, Inc. Quarterly Current Ratio in % from Q3 2019 to Q3 2024

Taxonomy & unit: ratio: %
Description: The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary: Trevi Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q3 2019 to Q3 2024.
Trevi Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2024 was 1.13K %, a 4.44% decline year-over-year.

Current Ratio, Quarterly (%)

Current Ratio, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q3 2024	1.13K	-52.4	-4.44%	Sep 30, 2024
Q2 2024	1.43K	+427	+42.3%	Jun 30, 2024
Q1 2024	1.7K	+920	+117%	Mar 31, 2024
Q4 2023	1.37K	+728	+114%	Dec 31, 2023
Q3 2023	1.18K	+684	+139%	Sep 30, 2023
Q2 2023	1.01K	+658	+188%	Jun 30, 2023
Q1 2023	783	+478	+157%	Mar 31, 2023
Q4 2022	638	+239	+59.8%	Dec 31, 2022
Q3 2022	494	-27.6	-5.29%	Sep 30, 2022
Q2 2022	350	-339	-49.2%	Jun 30, 2022
Q1 2022	305	-494	-61.8%	Mar 31, 2022
Q4 2021	399	-387	-49.2%	Dec 31, 2021
Q3 2021	522	-329	-38.6%	Sep 30, 2021
Q2 2021	690	-241	-25.9%	Jun 30, 2021
Q1 2021	799	-234	-22.6%	Mar 31, 2021
Q4 2020	787	-235	-23%	Dec 31, 2020
Q3 2020	850	-36	-4.06%	Sep 30, 2020
Q2 2020	931			Jun 30, 2020
Q1 2020	1.03K			Mar 31, 2020
Q4 2019	1.02K			Dec 31, 2019
Q3 2019	886			Sep 30, 2019

* An asterisk sign (*) next to the value indicates that the value is likely invalid.